Back to search
FDAFDA · Food and drugs·Recall number D-0558-2022

Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1768-36.

Published February 23, 2022 · Recall initiated: February 9, 2022

Summary

FDA records drug Class II recall D-0558-2022, published February 23, 2022 and initiated February 9, 2022. Recalling firm: Lannett Company, Inc.; Status: Terminated; Reported quantity: 23,598 bottles; Lot: Lot #: 2664A, 2664B, Exp. date 07/2022; 2874A, 2874B, Exp. date 01/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of specification results for related substances.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lannett Company, Inc.
Distributor
Product was distributed nationwide in the USA.
Lot
Lot #: 2664A, 2664B, Exp. date 07/2022; 2874A, 2874B, Exp. date 01/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1768-36. recalled?

Yes. FDA published recall D-0558-2022 on February 23, 2022. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification results for related substances.

What should I do if I have this product?

Voluntary: Firm initiated · Letter